Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series

Crit Care. 2020 May 15;24(1):227. doi: 10.1186/s13054-020-02928-0.

Alberto Zangrillo¹, Giovanni Landoni², Luigi Beretta¹, Federica Morselli¹, Ary Serpa Neto^{3

4}, Rinaldo Bellomo^{3

5

6

7}; COVID-BioB Study Group

COVID-BioB Study Group:
Anna Mara Scandroglio, Sergio Colombo, Antonio Dell'Acqua, Paolo Silvani, Evgeny Fominskiy, Giacomo Monti, Maria Luisa Azzolini, Antonio Bellantoni, Cristina Barberio, Gabriele Valsecchi, Omar Saleh, Gaetano Lombardi, Moreno Tresoldi, Paolo Scarpellini, Lorenzo Dagna, Fabio Ciceri, Yanase Fumitaka

¹ Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milano, Italy.
² Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milano, Italy. landoni.giovanni@hsr.it.
³ Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
⁴ Department of Critical Care Medicine, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
⁵ Department of Intensive Care, Austin Hospital, Melbourne, Australia.
⁶ Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.
⁷ Centre for Integrated Critical Care, School of Medicine, The University of Melbourne, Melbourne, Australia.

No abstract available

Publication types